Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-10ATNM3Kamal Adeela - Insider Filing for Actinium Pharmaceuticals, Inc.MEDIUM
This filing details insider transactions for Kamal Adeela, Chief Scientific Officer at Actinium Pharmaceuticals, Inc. It includes information on restricted stock units (RSUs) and stock options. 80,000 RSUs vest in three tranches on September 2, 2027, 2028, and 2029, with the remaining 133,648 RSUs vesting on September ...
Nano CapBiotechnology
2026-09-10ATNM3SEC Filing Summary for Actinium Pharmaceuticals, Inc.MEDIUM
This filing details changes in beneficial ownership for Steffen Heeger, Chief Medical Officer of Actinium Pharmaceuticals, Inc. Heeger holds 153,868 shares of Common Stock, represented by restricted stock units (RSUs) that vest fully on September 2, 2029. Additionally, he holds stock options to purchase 250,000 shares ...
Nano CapBiotechnology
2026-09-10CADL3Power of Attorney for Martine Zimmermann
This filing relates to a Power of Attorney granted by Martine Zimmermann, a director of Candel Therapeutics, Inc., to Paul Peter Tak and Charles Schoch. The attorneys-in-fact are authorized to execute and file various U.S. Securities and Exchange Commission (SEC) forms on behalf of Ms. Zimmermann, including Forms 3, 4,...
Small CapBiotechnology
2026-09-10IPSC3Power of Attorney for Joseph TruittMEDIUM
This filing details a Power of Attorney granted by Joseph Truitt, an officer and/or director of Century Therapeutics, Inc. (IPSC), to Brent Pfeiffenberger, Douglas Carr, and Gregory Russotti. The attorneys-in-fact are authorized to execute and file Forms 3, 4, and 5 on behalf of Mr. Truitt, in accordance with Section 1...
Small CapBiotechnology